Dr McCracken obtained his BSc in Biochemistry/Pharmacology from Strathclyde University, UK in 1988 and a PhD in Biochemical Toxicology from Newcastle University, UK in 1991. Following a post-doctoral position in pharmacogenetics, Dr McCracken moved into pharma, where he worked for Charles River and Abbot Laboratories within the field of DMPK. In 2005, Dr McCracken moved to Altana Pharma/Nycomed (Konstanz, DE) as Senior Director of DMPK and then in 2008 became VP of Exploratory & Translational Development. In 2010 joined Shire (Eysins, VD) to Head up Translational Medicine, with a focus on implementing modern translational concepts of drug development with the ultimate goal to bring to the market and position medicines that matter. He joined Debiopharm International SA in 2014.

Biochemical Toxicology